CDK Global has successfully renewed its DMS agreement with Sonic Automotive, securing a key partnership following two ...

Genentech’s parent company Roche said the $850m deal lines up with its plan to focus on three therapeutic areas including ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

In Hybrids amidst financial challenges. Read More CDK Global extends DMS contract with Sonic Automotive amid cyberattack ...

Numa, a startup developing AI-powered automation tech for car dealerships, has raised fresh capital in a Series B round.

Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth ...

As has been widely acknowledged, one of the most meaningful steps a business can take is to establish a single point of ...

A confident update to a grand Arts and Crafts residence learns from the home’s idiosyncratic heritage, responding with ...

Genentech to buy Regor's portfolio of next-generation CDK inhibitors to treat breast cancer: Cambridge, Massachusetts Tuesday, October 1, 2024, 10:00 Hrs [IST] Regor Pharmaceutica ...

The news reinforces CDK's reputation in the DMS business and, presumably, will help the company land more extensions and new ...

It hasn’t been the best of years for CDK Global, but it got some good news Monday. Sonic Automotive, one of the nation’s ...